L Gayani Tillekeratne
L Gayani Tillekeratne
Associate Professor of Medicine, Division of Infectious Diseases
Associate Research Professor, Global Health
Gayani Tillekeratne, MD MSc is an Associate Professor in the Division of Infectious Diseases and at the Duke Global Health Institute. Her work focuses on the improving the diagnosis and management of acute respiratory tract infections globally, with the goal of improving antimicrobial use for these infections. She is co-director of the Ruhuna-Duke Centre for Infectious Diseases in Sri Lanka and works with colleagues in Southeast Asia and East Africa. She is a co-investigator in several US clinical trials for COVID-19 vaccines and therapeutics. She co-instructs a course on Infectious Disease Epidemiology in Global Settings.
Projects
-
ACTIV-1 (COVID-19 therapeutic trial)
United States
-
RADx-UP CDCC (COVID-19 diagnostics)
United States
-
Partnership for Enhancing Antimicrobial Use in Resource-Limited Settings (PEARL)
Kenya, Sri Lanka, Tanzania
-
Surveillance for severe dengue in southern Sri Lanka
Sri Lanka
-
Novel Diagnostics to Improve Antimicrobial Stewardship for Acute Respiratory Tract Infections in Resource-Limited Settings
Sri Lanka
-
A One Health approach to antibiotic-resistant Enterobacteriaceae in South Asia
Sri Lanka
-
Antibiotic-resistant Enterobacteriaceae in community-acquired urinary tract infections, southern Sri Lanka
Sri Lanka
Publications
-
Ko ER, Reller ME, Tillekeratne LG, Bodinayake CK, Miller C, Burke TW, et al. Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance. Sci Rep. 2023 Dec 18;13(1):22554.Hanson KE, Banerjee R, Doernberg SB, Evans SR, Komarow L, Satlin MJ, et al. Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group. Clin Infect Dis. 2023 Oct 16;77(Suppl 4):S314–20.Narayanasamy S, Veldman TH, Lee MJ, Glover WA, Tillekeratne LG, Neighbors CE, et al. RADx-UP Testing Core: Access to COVID-19 Diagnostics in Community-Engaged Research with Underserved Populations. J Clin Microbiol. 2023 Aug 23;61(8):e0036723.Moorthy GS, Madut DB, Kilonzo KG, Lwezaula BF, Mbwasi R, Mmbaga BT, et al. Antibacterial Utilization for Febrile Illnesses and Laboratory-Confirmed Bloodstream Infections in Northern Tanzania. Open Forum Infect Dis. 2023 Aug;10(8):ofad448.
See more publications at Scholars@Duke